Related Experiment Videos
Is clonidine a behavioural teratogen in the human?
Early Human Development
|July 1, 1986
Summary
Prenatal exposure to clonidine in children showed no significant differences in development, except for increased hyperactivity and sleep issues. Further research is needed to confirm clonidine
Area of Science:
- Pediatric Pharmacology
- Neurodevelopmental Studies
Background:
- Maternal hypertension during pregnancy necessitates treatment, with potential impacts on fetal development.
- Clonidine is an antihypertensive medication sometimes used during pregnancy.
Purpose of the Study:
- To evaluate the long-term neurodevelopmental and behavioral effects of prenatal clonidine exposure in children.
- To compare children exposed prenatally to clonidine with a matched control group.
Main Methods:
- A cohort of 22 children with prenatal clonidine exposure was compared to a matched control group.
- Participants were assessed at a mean age of 6.3 years.
- Comparisons included head circumference, neurological findings, school performance, and behavioral characteristics.
Main Results:
- No significant differences were observed in head circumference, neurological status, or school performance.
- A marginal increase in hyperactivity and a significant excess of sleep disturbances were noted in the clonidine-exposed group.
- These findings suggest potential, though not definitive, effects of prenatal clonidine exposure.
Conclusions:
- Prenatal clonidine exposure may be associated with increased hyperactivity and sleep disturbances in children.
- The observed effects warrant further investigation, including dose-response studies and animal model correlations, to confirm a direct causal link.